Sygnature Discovery

Mitigating Hazardous Reactions Through Continuous Flow: Sygnature Discovery’s Success with Syrris Asia

Sygnature Discovery has had success using the Asia Flow Chemistry System from Syrris to safely work with two hazardous reagents on a considerable scale.

Top-Feature

CHEManager c/o Wiley-VCH Verlag

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Expert Insights

Advancements in Bispecific Antibody Development

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Syrris

Sygnature Discovery

Mitigating Hazardous Reactions Through Continuous Flow: Sygnature Discovery’s Success with Syrris Asia

Top-Feature

Upcoming Virtual Events

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Expert Insights

Dual‑Targeting Breakthroughs

Sygnature Discovery

Mitigating Hazardous Reactions Through Continuous Flow: Sygnature Discovery’s Success with Syrris Asia

Top-Feature

Upcoming Virtual Events

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Expert Insights

Dual‑Targeting Breakthroughs

Newsletter & e-edition